LASIX sol inj 20 mg/2ml 5 amp 2 ml
7680306300177
CH-30630
C03CA01
05.01.0.
1 / 3
google
Details
- Product number
- 3063001
- CPT
- -
- Packaging group
- 5
- Unit
- Ampulle(n)
- Composition
- furosemidum 20 mg ut furosemidum natricum, natrii hydroxidum, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium 7.4 mg.
Articles (1)
Lasix 20 mg/2 mL, solution injectable
Injektionslösung
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.4 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 11.00
Specialties list
Yes
Generic
No
SL addition date:
15/03/1965
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 30630
- Drug name
- Lasix, solution injectable
- Galenic form
- LSPA
- ATC Code
- C03CA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/09/1964
- Authorization expiration date
- 31/12/9999
- IT number
- 05.01.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LASIX sol inj 20 mg/2ml 5 amp 2 ml
- Description (DE)
- LASIX Inj Lös 20 mg/2ml 5 Amp 2 ml
- Market launch
- 01/09/1964
- Narcotic (BTM)
- No